ArticleScientific reports2025
Analysis of the characteristics of mixed infections with Mycoplasma pneumoniae in children.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Association between point mutations of macrolide-resistantFrontiers in pharmacology · 2025Pooled it
- Etiological characterization of acute respiratory tract infections and associated co-infections using Biofire respiratory 2.1 Plus panel.BMC infectious diseases · 2026Article
- Infectious serology patterns in clinically diagnosed erythema multiforme.JAAD international · 2026Article
- Post-pandemic resurgence of Mycoplasma pneumoniae and its emerging link with Rhinovirus in children.Infection · 2026Article
- Clinical and laboratory features of pediatric Mycoplasma pneumoniae Pneumonia with viral versus bacterial co-infection.Italian journal of pediatrics · 2026Article
- Analysis of the pathogen spectrum and epidemiological characteristics of hospitalized children with pneumonia from 2017 to 2024.BMC infectious diseases · 2026Article
- Epidemiology ofEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026Article
- Clinical characteristics, risk factors, and pathogen spectrum of mixed infections in children withMicrobiology spectrum · 2026Article
- Coinfection Patterns ofInternational journal of molecular sciences · 2026Article
- Predicting societal risk factors for respiratory co-infections: a cross-sectional study based on multi-source fever clinic data.BMC infectious diseases · 2026Article
- Host inflammatory markers and MLVA profiling for risk assessment of severe pediatricFrontiers in cellular and infection microbiology · 2026Article
- Etiological composition and epidemiological characteristics of acute respiratory infections in Hebei Province, 2023-2025.Frontiers in public health · 2026Article
- Genomic surveillance of the pneumonia outbreak caused byFrontiers in cellular and infection microbiology · 2026Article
- Epidemiology and co-infection networks of pediatric respiratory pathogens in eastern China after COVID-19 restriction relaxation: a retrospective study.Frontiers in cellular and infection microbiology · 2026Article
- Levels of Toll-Like Receptor 2, Myeloid Differentiation Primary Response 88 and Mucin 5AC, Oligomeric Mucus/Gel-Forming in Bronchoalveolar Lavage Fluid for Predicting SevereInfection and drug resistance · 2026Article
- Article
- Mycoplasma pneumoniae in hospitalised children in the post-COVID era: clinical outcomes from a Turkish multicenter cohort.European journal of pediatrics · 2025Article
- Basal Ganglia Involvement in PediatricEpidemiologia (Basel, Switzerland) · 2025Article
- Clinical score for early escalation in pediatric A2063G Mycoplasma pneumoniae pneumonia: a retrospective cohort study.BMC infectious diseases · 2025Article
- Correlation analysis between clinical characteristics of adult patients with Mycoplasma pneumoniae pneumonia and 23S rRNA A2063 gene in alveolar lavage fluid.BMC pulmonary medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
353 hospitalized children diagnosed with Mycoplasma pneumoniae (MP) pneumonia were included in the study. They were divided into MP co-infection group and MP single infection group. 143 (40.5%) of the enrolled children had MP co-infections. The most common co-infecting pathogen was Rhinovirus (30.8%). Among the MP co-infections, 82 cases (57.3%) involved one pathogen, 44 cases (30.7%) involved two pathogens, 12 cases (8.4%) involved three pathogens, 4 cases (2.8%) involved four pathogens, and 1 case (0.7%) involved five pathogens. Significant differences were observed between the two groups in terms of severe MP pneumonia, macrolide resistance, bronchial mucus plug, and hormone use, with P-values of 0.039, 0.000, 0.000, and 0.035. The MP mixed virus or bacteria infection group was more likely to develop drug resistance compared to the mixed virus and bacteria group (P = 0.007 and P = 0.046). The MP mixed virus and bacteria group was more likely to develop severe pneumonia compared to the mixed virus or bacteria infection group (P = 0.032 and P = 0.017). In conclusion, MP was most commonly co-infected with Rhinovirus. Children with MP co-infections tend to exhibit higher rates of macrolide resistance, require more frequent use of hormones, and are more likely to develop severe pneumonia and bronchial mucus plug.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.